Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-16 · accession 0001062993-23-022819 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-19 | 2023-12-16 | BIO | WRIGHT DARA | EVP, Pres, CDG | M - OptEx | $0.00 | +502 | 2,001 | +33% | $0 |
| D | 2023-12-19 | 2023-12-16 | BIO | WRIGHT DARA | EVP, Pres, CDG | F - Tax | $306.12 | -174 | 1,827 | -9% | -$53.3K |
| D | 2023-12-19 | 2023-12-16 | BIO | WRIGHT DARA | EVP, Pres, CDG | M - OptEx | $0.00 | -502 | 503 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-12-16 | M | A | 502 | $0.00 | 2,001.08 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2023-12-16 | F | D | 174 | $306.12 | 1,827.08 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-12-16 | M | D | 502 | $0.00 | 503 | D | $0.00 · — to — | 502 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date. |